Vascular surgeon Dr. Hector Crespo Soto of the Sanger Heart and Vascular Institute of Atrium Health was the first physician to use SurgiBind commercially outside of a study.
“I used the product in a ray amputation surgery, and I was pleased with the outcome. There were no post-op complications; the incision stayed closed and healed quickly. The Kerecis product compliments surgical procedures, provides a bacterial barrier and reinforces the body’s healing mechanism.”
This is a one hour webinar that is repeated at 9pm ET.
Webinar host will be Bill Wagner VP of Surgical & Burn Segments at Kerecis.
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.
Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.
© 2010-2024 Kerecis. All Rights Reserved